does tirzepatide cause vision problems Mounjaro Eye Side Effects Lawsuit [2026 Update] Ophthalmic complications observed in patients

Vaduganathan M, Mensah George A, Turco Justine V, Fuster V, Roth GA

J., Koeth, R., Levison, B

Nightmares and sleep disturbances are not listed as recognised adverse effects in the MHRA-approved Summary of Product Characteristics or pivotal STEP trials

By replenishing vital nutrients, our therapy helps you bounce back quicker and reduces the risk of future infections

BPC-157 (Body Protection Compound-157) is a 15 amino-acid peptide derived from a naturally occurring protein found in the stomach

Amgen is developing a GLP-1/GIP dual agonist called MariTide (currently in phase 3 trials expected to complete in 2027), which is administered as a once-monthly injection